Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
0 hedge funds and large institutions have $0 invested in Oxford Immunotec Global PLC Ordinary Shares in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 60 closing their positions.
100% less funds holding
Funds holding: 60 → 0 (-60)
100% less funds holding in top 10
Funds holding in top 10: 5 → 0 (-5)
100% less capital invested
Capital invested by funds: $400M → $0 (-$400M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 60
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$86.4M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$44.9M |
| 3 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$39.1M |
| 4 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
-$33.8M |
| 5 |
SM
Senvest Management
New York
|
-$25.7M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EMG
51
ETF Managers Group
Summit,
New Jersey
| – | -$217K | -12,628 | Closed |
|
52
BlackRock
New York
| – | -$100K | -5,723 | Closed |
|
53
Barclays
London,
United Kingdom
| – | -$44K | -2,500 | Closed |
|
|
TRCT
54
Tower Research Capital (TRC)
New York
| – | -$40K | -2,279 | Closed |
|
|
RE
55
RBC Europe
London,
United Kingdom
| – | -$21.4K | -1,225 | Closed |
|
56
US Bancorp
Minneapolis,
Minnesota
| – | -$17K | -965 | Closed |
|
57
Citigroup
New York
| – | -$16K | -928 | Closed |
|
58
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$13K | -718 | Closed |
|
59
Morgan Stanley
New York
| – | -$4K | -225 | Closed |
|
|
S
60
SignatureFD
Atlanta,
Georgia
| – | -$3K | -162 | Closed |
|
OXFD Hedge Fund Activity: Q1 2021 in Review
0 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q1 2021, worth a combined $0 — down 100% from $400M a quarter earlier.
Sellers outnumbered buyers: 60 funds closed out of OXFD and 0 opened new positions — a net loss of 60 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was First Light Asset Management, exiting entirely with an estimated $86.4M sold.
- 0 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q1 2021, down from 60 in Q4 2020.
- Funds reported $0 of Oxford Immunotec Global PLC Ordinary Shares stock for Q1 2021, down 100% quarter-over-quarter.
- 0 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q1 2021 and 60 closed out, a net change of -60 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q1 2021 was First Light Asset Management, an estimated $86.4M sold.
Based on aggregated 13F filings for Q1 2021.